BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
169.5124332
NSE Symbol
EMCURE
Divident Yield %
0.22
Market Cap
(Rs In Cr.)
26,262
P/E (TTM)
60.68
EPS (TTM)
22.83
Face Value
(Rs)
10
Back
Emcure Pharmaceuticals consolidated net profit rises 25.13% in the September 2025 quarter
11-Nov-25   Hrs IST

Net profit of Emcure Pharmaceuticals rose 25.13% to Rs 243.46 crore in the quarter ended September 2025 as against Rs 194.57 crore during the previous quarter ended September 2024. Sales rose 13.38% to Rs 2269.82 crore in the quarter ended September 2025 as against Rs 2001.98 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales2269.822001.98 13
OPM %20.9519.03 -
PBDT446.06370.31 20
PBT341.42273.41 25
NP243.46194.57 25

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)